Douglas E. Williams

2013 - Biogen

In 2013, Douglas E. Williams earned a total compensation of $5.2M as Former EVP, Research and Development at Biogen, a 32% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$720,036
Salary$766,831
Stock Awards$3,575,514
Other$184,017
Total$5,246,398

Williams received $3.6M in stock awards, accounting for 68% of the total pay in 2013.

Williams also received $720K in non-equity incentive plan, $766.8K in salary and $184K in other compensation.

Rankings

In 2013, Douglas E. Williams' compensation ranked 1,183rd out of 12,286 executives tracked by ExecPay. In other words, Williams earned more than 90.4% of executives.

ClassificationRankingPercentile
All
1,183
out of 12,286
90th
Division
Manufacturing
386
out of 4,612
92nd
Major group
Chemicals And Allied Products
103
out of 1,466
93rd
Industry group
Drugs
66
out of 1,160
94th
Industry
Biological Products, Except Diagnostic Substances
8
out of 200
96th
Source: SEC filing on April 15, 2016.

Williams' colleagues

We found five more compensation records of executives who worked with Douglas E. Williams at Biogen in 2013.

2013

George Scangos

Biogen

Chief Executive Officer

2013

Paul Clancy

Biogen

Chief Financial Officer

2013

Raymond Pawlicki

Biogen

Former SVP, Chief Information Officer

2013

Stuart Kingsley

Biogen

Former EVP, Global Operations

2013

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

News

You may also like